You are here
Intra-Cellular Therapies to Present at the 8th Annual SVB Leerink Global Healthcare Conference
NEW YORK, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the 8th Annual SVB Leerink Global Healthcare Conference in New York. The presentation is scheduled for Thursday, February 28, 2019 at 2:00 pm ET.
Thursday, February 21, 2019 - 08:00